Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

The Soluble Isoform of CTLA-4 Correlates with Interferon-α Activity in Systemic Lupus Erythematosus

LEKH N. DAHAL, ROBERT N. BARKER and FRANK J. WARD
The Journal of Rheumatology February 2020, 47 (2) 302-304; DOI: https://doi.org/10.3899/jrheum.190678
LEKH N. DAHAL
MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool;
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT N. BARKER
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANK J. WARD
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mmd475@abdn.ac.uk L.N.Dahal@liverpool.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Information

vol. 47 no. 2 302-304
DOI 
https://doi.org/10.3899/jrheum.190678
PubMed 
31787598

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online February 1, 2020.

Article Versions

  • Latest version (December 1, 2019 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020

Author Information

  1. LEKH N. DAHAL, PhD
  1. MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool;
  1. ROBERT N. BARKER, PhD
  1. FRANK J. WARD, PhD⇑
  1. Immunity, Infection and Inflammation group, Division of Applied Medicine, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, UK.
  1. Address correspondence to F.J. Ward, University of Aberdeen, Immunity, Infection and Inflammation group, Division of Applied Medicine, Institute of Medical Sciences, Foresterhill, Aberdeen, UK. E-mail: mmd475{at}abdn.ac.uk or L.N. Dahal, L.N.Dahal{at}liverpool.ac.uk

Article usage

Article usage: November 2019 to April 2025

AbstractFullPdf
Nov 2019100
Dec 2019175049
Jan 202067232
Feb 202030580832
Mar 20206741619
Apr 20204436721
May 20203639518
Jun 202023228
Jul 2020173426
Aug 2020231912
Sep 2020211828
Oct 2020103616
Nov 202020289
Dec 2020271315
Jan 2021182013
Feb 202115198
Mar 2021111012
Apr 2021994
May 2021498215
Jun 2021172321
Jul 20213158
Aug 202191813
Sep 202183821
Oct 202152122
Nov 20213618
Dec 20213209
Jan 20227711
Feb 20226158
Mar 202221118
Apr 20221899
May 20222514
Jun 20220108
Jul 2022465
Aug 20221107
Sep 20222914
Oct 20229107
Nov 202251011
Dec 2022226
Jan 2023395
Feb 20239125
Mar 20238114
Apr 2023297
May 202311020
Jun 20235104
Jul 202341718
Aug 20231058
Sep 2023342
Oct 20234810
Nov 202381510
Dec 202311911
Jan 2024373
Feb 202422148
Mar 20243910
Apr 202491116
May 20244237
Jun 202411210
Jul 2024189
Aug 202451811
Sep 202451110
Oct 20242917
Nov 20244106
Dec 2024379
Jan 2025315
Feb 202592710
Mar 20254913
Apr 20256174

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 47, Issue 2
1 Feb 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Soluble Isoform of CTLA-4 Correlates with Interferon-α Activity in Systemic Lupus Erythematosus
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Soluble Isoform of CTLA-4 Correlates with Interferon-α Activity in Systemic Lupus Erythematosus
LEKH N. DAHAL, ROBERT N. BARKER, FRANK J. WARD
The Journal of Rheumatology Feb 2020, 47 (2) 302-304; DOI: 10.3899/jrheum.190678

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
The Soluble Isoform of CTLA-4 Correlates with Interferon-α Activity in Systemic Lupus Erythematosus
LEKH N. DAHAL, ROBERT N. BARKER, FRANK J. WARD
The Journal of Rheumatology Feb 2020, 47 (2) 302-304; DOI: 10.3899/jrheum.190678
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Seasonal Variations and Their Influence on Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Relapse
  • Survival After Lung Transplantation in Patients With Rheumatoid Arthritis-Associated Lung Disease
  • High-Sensitivity Cardiac Troponin T as a Marker to Improve Cardiovascular Disease Risk Assessment Among Patients With Rheumatoid Arthritis
Show more Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire